| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |